Caladrius Biosciences (CLBS) Gains Amid FDA Fast Track Designation for CLBS03 for Type 1 Diabetes – StreetInsider.com

Get day-to-day under-the-radar research along with StreetInsider.com’s Stealth Growth Insider Get your 2-Wk Free Trial here . Caladrius ...

Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes – Yahoo Finance

PARIS, July 27, 2016 /PRNewswire/ —  Sanofi announced today that the U.S. Meals and Drug Administration (FDA) approved Adlyxin TM (lixisen...

Frontier Pharma Report 2016: Diabetic Complications – Innovative and Diverse Neuropathies, Nephropathy and … – Yahoo Finance

DUBLIN–(Company WIRE)– Research and Markets has actually announced the addition of the “Frontier Pharma: Diabetic Troubles – Innovative an...

Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes – GlobeNewswire (press release)

July 28, 2016 07:30 ET | Source: Caladrius Biosciences, Inc. BASKING RIDGE, N.J., July 28, 2016 (GLOBE NEWSWIRE) — Caladrius Biosciences,...

Daily Binge Watching Linked To Heightened Risk Of Blood Clot Deaths – Huffington Post

By Kathryn Doyle (Reuters Health) – People that watch television for 5 or much more hrs a day have actually much more compared to two times...

Discovery of biomarkers for the prognosis of chronic kidney disease – Science Daily

Currently, there is no efficient means to predict the prognosis of chronic kidney illness (CKD) patients. Tomonori Kimura and Yoshitaka Isak...

Researchers identify biomarkers to improve prognosis of CKD – News-Medical.net

Published on July 27, 2016 at 7:11 AM Currently, there is no efficient way to predict the prognosis of chronic kidney health problem (CKD) ...